| Authors: |
Palomba ML; Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: palombam@mskcc.org., Schuster SJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Karmali R; Northwestern University Feinberg School of Medicine, Robert H Lurie Comprehensive Cancer Center, Chicago, IL, USA., Skarbnik AP; Novant Health Cancer Institute, Charlotte, NC, USA., Abramson JS; Lymphoma Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Ardeshna K; University College London Hospitals Biomedical Research Centre, London, UK., Borchmann P; Universität zu Köln, Albertus-Magnus-Platz, Cologne, Germany., Hill BT; Cleveland Clinic, Cleveland, OH, USA., García-Sancho AM; Hospital Universitario de Salamanca, IBSAL, CIBERONC, Universidad de Salamanca, Salamanca, Spain., Marcacci G; National Cancer Institute, Fondazione 'G Pascale', IRCCS, Naples, Italy., Rapoport AP; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Cartron G; Montpellier University Hospital Center, UMR CNRS, Montpellier, France., Fleury I; Hôpital Maisonneuve-Rosemont, Montreal, QC, Canada., Izutsu K; National Cancer Center Hospital, Chuo City, Tokyo, Japan., Kamdar M; University of Colorado Cancer Center, Aurora, CO, USA., Mielke S; Departments of Laboratory Medicine and Medicine at Huddinge, Center of Allogeneic Stem Cell Transplantation and Cellular Therapy, Karolinska Institutet and University Hospital, Karolinska Comprehensive Cancer Center, Karolinska ATMP Center, H5 Laboratories Medicine, Stockholm, Sweden., Barbui AM; Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy., Ortega JLR; Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, Universidad de Sevilla, Seville, Spain., Nastoupil LJ; Southwest Oncology, CommonSpirit Mercy, Durango, CO, USA., Ahmed S; MD Anderson Cancer Center, Houston, TX, USA., Bar M; Bristol Myers Squibb, Boudry, Switzerland., Diaz L; Bristol Myers Squibb, Boudry, Switzerland., Furustrand U; Bristol Myers Squibb, Boudry, Switzerland., Diab V; Bristol Myers Squibb, Princeton, NJ, USA., Vedal M; Bristol Myers Squibb, Boudry, Switzerland., Avilion A; Bristol Myers Squibb, Seattle, WA, USA., Kumar J; Bristol Myers Squibb, Princeton, NJ, USA., Nishii R; Bristol Myers Squibb, Princeton, NJ, USA., Colicino S; Bristol Myers Squibb, Boudry, Switzerland., Morschhauser F; Département d'Hématologie, Université de Lille, Centre Hospitalier Universitaire de Lille, Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France. |
